Importantly, fusion peptides consisting of the survival protein AAC-11 residues 377–399 linked to the C-terminus of hAP10 or hAP10DR exhibited remarkable anticancer properties both ex vivo and in a mouse model of Sézary syndrome. This evidence concerns the gene PROS1 and Sezary syndrome.